Results 241 to 250 of about 755,388 (347)

Citrullination of AKT2 Catalyzed by PAD1 Facilitates the Maintenance of Stemness Characteristics of Ovarian Cancer Stem-Like Cells in Ovarian Cancer. [PDF]

Adv Sci (Weinh)
Xue T, Liu X, Song C, Fei S, Gu J, Han Y, Xing J, Liu X, Liang F, Thompson PR, Zhang X.   +10 more
europepmc   +1 more source

Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells

, 2017
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, Ivana Vancurova   +3 more
openalex   +2 more sources

NIR Ratiometric Fluorescent Antibody‐Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring

Advanced Science, EarlyView.
In vivo optical imaging enhances antibody‐drug conjugate (ADC) optimization by enabling real‐time monitoring of stimulus‐responsive drug behavior. We report n501‐CYMMAF, a ratiometric theranostic with strong target affinity and low‐dose efficacy for ovarian metastasis.
Cheng Li, Zezhong Yu, Tao Pu, Yanling Wu, Gang Wang, Youhua Xie, Tianlei Ying, Zhenlin Yang, Yibing Shi   +8 more
wiley   +1 more source

T-cell receptor therapy in ovarian cancer: concepts and challenges. [PDF]

J Ovarian Res
Wang X, Li Z, Zhang M, Yu Y, Tong W.
europepmc   +1 more source

Aptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next‐Generation Diagnostics and Biosensing

Advanced Science, EarlyView.
The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen, Ahlem Meziadi, Cyrill Brunner, Maureen McKeague, Lidija Malic, Maryam Tabrizian   +5 more
wiley   +1 more source

NETs in ovarian cancer progression: innovative nanoparticle-based therapeutic strategies. [PDF]

Eur J Med Res
Moradpanah S, Aghaei ZH, Eslamnik P, Goldiani NK, Sargolzaei Z, Doosty F, Barsam M, Feli M, Zarifi N.   +8 more
europepmc   +1 more source

Core Fucosylation Represses SMURF1‐Dependent Degradation of CD47 to Promote Tumor Immune Evasion

Advanced Science, EarlyView.
FUT8‐mediated core fucosylation of CD47 at N111 blocks SMURF1 binding and reduces CD47 ubiquitination and degradation. Blocking N111 glycosylation reduces CD47 expression and promotes macrophage phagocytosis of tumor cells. Furthermore, ablating CD47 core fucosylation boosts CD103+ dendritic cells (DCs) infiltration, increases natural killer (NK) cell ...
Yuting Cao, Siyuan Chai, Mingyang Li, Xiaoming Chen, Jiating Hu, Bingyi Lin, Liming Wu, Wen Yi, Qiang Zhu   +8 more
wiley   +1 more source

Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications. [PDF]

Cancer Imaging
Huang Y, Peng W, Yang H, Liu Z, Zhang T, Jin L, He W, Du M, Chen Z.   +8 more
europepmc   +1 more source

The effect of talc particles on phagocytes in co-culture with ovarian cancer cells

, 2019
Angelo Mandarino, David J. Gregory, Connor C. McGuire, Brian W. LeBlanc, Hadley Witt, L. M. Rivera, John J. Godleski, Alexey V. Fedulov   +7 more
openalex   +2 more sources

The Immune Microenvironment in Liver Cancer: From Analysis to Targeting

Advanced Science, EarlyView.
This review explores how smart nanomedicines overcome the immunosuppressive tumor microenvironment in liver cancer. It details targeted delivery strategies and immune reprogramming mechanisms, including remodeling abnormal physiology, modulating metabolism, and inducing immunogenic cell death. The article highlights the paradigm shift toward multimodal
Jiaming Lan, Hao Li, Jian Xue, Yourong Duan, Jin Sun, Meng Niu   +5 more
wiley   +1 more source